SlideShare a Scribd company logo
THE BERLIN PATIENT:
HISTORICALTRIUMPH OF MEDICAL SCIENCE
Today we are going to discuss about another remarkable victory
of medical science .
OUR BIG
IDEA
2
HIV is a virus that targets and alters the immune system,
increasing the risk and impact of other infections and diseases.
Without treatment, the infection might progress to an advanced
disease stage called AIDS.
EXPLAINING HIVANDAIDS BRIEFLY
What is HIV?
Human immunodeficiency virus (HIV) is a virus that attacks immune cells called CD4 cells, which are a type of T cell.
These are white blood cells that move around the body, detecting faults and anomalies in cells as well as infections.
When HIV targets and infiltrates these cells, it reduces the body's ability to combat other diseases. This increases the
risk and impact of opportunistic infections and cancers. However, a person can carry HIV without experiencing
symptoms for a long time. HIV is a lifelong infection. However, receiving treatment and managing the disease effectively
can prevent HIV from reaching a severe level and reduce the risk of a person passing on the virus.
What is AIDS?
AIDS is the most advanced stage of HIV infection. Once HIV infection develops into AIDS, infections and cancer pose a
greater risk. Without treatment, HIV infection is likely to develop into AIDS as the immune system gradually wears
down.
3
Causes
HIV is a sexually transmitted infection (STI). It can also be spread by contact with infected blood or from
mother to child during pregnancy, childbirth or breast-feeding.
Symptoms
Some people with HIV do not show symptoms until months or even years after contracting the virus.
However, around 80 percent of people may develop a set of flu-like symptoms known as acute retroviral
syndrome. The early symptoms of HIV infection may include: Fever, chills, joint pain, muscle aches, sore
throat, Sweats(particularly at night), enlarged glands, a red rash, tiredness.
Without medication, HIV weakens the ability to fight infection. The person becomes vulnerable to serious
illnesses. Symptoms of late-stage HIV infection may include: i)blurred vision, ii)diarrhoea, which is usually
persistent or chronic, iii)dry cough, a fever of over 100 °F (37 °C) lasting for weeks, iv)night sweats,
v)permanent tiredness, shortness of breath, or dyspnoea, swollen glands lasting for weeks, vi)unintentional
weight loss, white spots on the tongue or mouth.
4
HIV LIFECYCLE
Stages of HIV lifecycle:
5
1. Binding and fusion
The virus attaches itself to a T-helper cell and releases HIV into the cell.
2. Conversion and integration
Once inside the T-helper cell, HIV changes its genetic material so it can enter the nucleus of the cell and
take control of it.
3. Replication
The infected T-helper cell then produces more HIV proteins that are used to produce more HIV particles
inside the cell.
4. Assembly, budding and maturation
The new HIV particles are then released from the T-helper cell into the bloodstream which infect other
cells; and so the process begins again.
WHO IS “ THE BERLIN PATIENT ” ?
Timothy Ray Brown (born 1966) is an American considered to be the first person cured of HIV/AIDS.
Brown was called "The Berlin Patient" at the 2008 Conference on Retroviruses and Opportunistic
Infections, where his cure was first announced, in order to preserve his anonymity, and because he lived
in, and was treated in Berlin. He chose to come forward in late 2010. “I didn’t want to be the only person
cured,” he said. “I wanted to do what I could to make [a cure] possible. My first step was releasing my name
and image to the public.”
6
PROCEDURE(HOWDIDBROWNRIDHIMSELFOFHIV):
7
Brown was diagnosed with HIV in 1995 while studying in Berlin, Germany. After controlling the virus for
many years with antiretroviral therapy, Brown was diagnosed with Acute Myeloid Leukaemia (AML) and
in 2007 underwent stem cell transplantation after unsuccessful chemotherapy . His physician, Dr. Gero
Hütter, at Charité Hospital in Berlin, arranged for him to receive a hematopoietic stem cell transplant from a
donor with the "delta32" mutation on the CCR5 receptor. Despite enduring complications and undergoing a
second transplant from the same donor in 2008, the outcome was ultimately a success. Nearly eight years
after his transplant, Brown remains free of both his cancer and readily detectable HIV.
VARIOUS STEPS THAT HAD PLAYED SIGNIFICANT
ROLE IN THE TREATMENT
Figure1: Genotyping of CCR5 Alleles
8
(Contd.)
VARIOUS STEPS THAT HAD PLAYED SIGNIFICANT ROLE IN
THE TREATMENT(CONTD.)
Figure 2: Cellular and Humoral Immune Response to HIV-1
9
(Contd.)
VARIOUS STEPS THAT HAD PLAYED SIGNIFICANT ROLE IN
THE TREATMENT(CONTD.)
Figure 3: Clinical Course and HIV-1 Viremia
10
Figure 4: Expression of CD Surface Antigen and
Chemokine Core receptor in the patient’s rectal
mucosa
TEN YEARSAFTER THE ‘BERLIN PATIENT,’ DOCTORS
ANNOUNCEASECOND PERSON HAS BEEN EFFECTIVELY
‘CURED’ OF HIV
11
For the second time, doctors appear to have put HIV into “sustained remission” with a stem cell
transplant-effectively curing the recipient.
The researchers reported in the journal Nature what they hope will be a triumph: a man in London
H.I.V. and may have been cured of the infection. The London Patient, as he is being called, first
and then later developed Hodgkin’s lymphoma. The cancer was resistant to standard chemotherapy, so
advised more intensive chemotherapy, along with a bone-marrow transplant.
He received bone-marrow stem cells from a healthy donor who had the CCR5 mutation. When the
Patient’s immune system regrew after the transplant, it lacked the protein and was impervious to the
contracted. Unable to take root in his cells, the virus appears to have passed. Unlike Brown, though, this
cancer treatment didn’t involve full-body radiation, and his chemotherapy was also far gentler.
HIV research has come a long way since the disease was discovered in the 1980’s.
Antiretroviral therapy was a major milestone that has changed the lives of millions.
APOSSIBILITY OF HIV FREE WORLD
‘The Berlin Patient’, Timothy Ray Brown, became first person to be effectively cured of HIV in 2007. If
indeed, Timothy Brown has been functionally cured of his HIV infection, he then has provided us with a
blueprint from which to work. In fact, much of our ongoing research endeavours were inspired by the
biological mechanisms likely exploited to bring about this breakthrough. By reverse engineering his
pathway to cure, we hope to recapitulate his success and develop a feasible therapy approach that would
be available to the vast majority of HIV-infected individuals.
Nearly 12 years after “The Berlin patient” doctors announced a second person has been effectively ‘cured’
of HIV. The treatment procedure was almost similar to that of Brown. These two cases provide a proof of
principle about the potential of stem cells that lack CCR5. Those techniques may be used to genetically
alter the cells of people with H.I.V., inactivating the CCR5 gene. Those people should then become
resistant to the virus, and hopefully recapitulate the outcomes of the Berlin and London patients.
12
REFERENCE
13
https://www.mayoclinic.org/diseases-conditions/hiv-aids/symptoms-causes/syc-20373524https://www.avert.org/about-
hiv-aids/how-infects-body
https://en.wikipedia.org/wiki/Timothy_Ray_Brown
https://en.wikipedia.org/wiki/Berlin_Patient
http://defeathiv.org/berlin/
https://www.nejm.org/doi/full/10.1056/NEJMoa0802905
https://www.statnews.com/2019/03/04/second-person-effectively-cured-of-hiv/
https://www.newyorker.com/news/daily-comment/the-london-patient-and-a-plan-to-end-the-hiv-epidemic-in-the-united-
states
ACKNOWLEDGEMENT
14
Our team would like to express our deepest appreciation to all those who provided us the possibility to
complete this report. A special gratitude we give to our respected teacher, Ms. Meenakshi Dey, whose
contribution in stimulating suggestions and encouragement, helped us to coordinate our project especially
in writing this report.
We have to appreciate the guidance given by other supervisor as well as the panels especially in our
project presentation that has improved our presentation skills thanks to their comment and advices.
THANK
YOU
Akanksha Kumari
17/CSE/118
Adriza Bera
Aditya Kumar
Aishik Das
Aditya Prakash
Adarsha Dinda
17/CSE/120
17/CSE/119
17/CSE/121
17/CSE/122 17/CSE/123

More Related Content

What's hot

Car tcell therapy
Car tcell therapyCar tcell therapy
Car tcell therapy
preetika pradhan
 
Hsct copy
Hsct   copyHsct   copy
Hsct copy
Nilesh Kucha
 
Neuroendocrine tumors of the lung (seminar)
Neuroendocrine tumors of the lung (seminar)Neuroendocrine tumors of the lung (seminar)
Neuroendocrine tumors of the lung (seminar)
MIMSR Medical college,Latur
 
HLA in Health & Disease
HLA in Health & DiseaseHLA in Health & Disease
HLA in Health & Disease
Dr. Anuja Joshi
 
Know your COVID-19 Vaccine (Philippines)
Know your COVID-19 Vaccine (Philippines)Know your COVID-19 Vaccine (Philippines)
Know your COVID-19 Vaccine (Philippines)
AxcelPerez1
 
20160219 Livia Marcato - Cell Free DNA and Liquid Biopsy
20160219 Livia Marcato - Cell Free DNA and Liquid Biopsy 20160219 Livia Marcato - Cell Free DNA and Liquid Biopsy
20160219 Livia Marcato - Cell Free DNA and Liquid Biopsy
Roberto Scarafia
 
Tumour immunology
Tumour immunologyTumour immunology
Tumour immunology
Milan Taradi
 
Precision Medicine in Oncology Informatics
Precision Medicine in Oncology InformaticsPrecision Medicine in Oncology Informatics
Precision Medicine in Oncology Informatics
Warren Kibbe
 
Flowcytometry
FlowcytometryFlowcytometry
Flowcytometry
Badheeb
 
autologous bone marrow transplant
autologous bone marrow transplantautologous bone marrow transplant
autologous bone marrow transplant
Anam Khurshid
 
Cancer Immuno editing
Cancer Immuno editingCancer Immuno editing
Cancer Immuno editingSurayya Sana
 
Nick chen ppt presentation metronomic chemotherapy 2015
Nick chen   ppt presentation metronomic chemotherapy 2015Nick chen   ppt presentation metronomic chemotherapy 2015
Nick chen ppt presentation metronomic chemotherapy 2015
CNPS, LLC
 
Cytokines
CytokinesCytokines
Cytokines
Pooja Sevak
 
Gleason grading system
Gleason grading systemGleason grading system
Gleason grading system
Eko indra
 
Lect 6 a measles, mumps and rubella
Lect 6 a measles, mumps and rubellaLect 6 a measles, mumps and rubella
Lect 6 a measles, mumps and rubella
Dr. Riaz Ahmad Bhutta
 
Stem Cell Transplantation in Hodgkin’s Lymphoma Past, Present and Future
Stem Cell Transplantation in  Hodgkin’s Lymphoma  Past, Present and FutureStem Cell Transplantation in  Hodgkin’s Lymphoma  Past, Present and Future
Stem Cell Transplantation in Hodgkin’s Lymphoma Past, Present and Future
Amir Abbas Hedayati Asl
 
Cancer vaccines
Cancer vaccinesCancer vaccines
Cancer vaccines
bharti rakhecha
 
GRAFT VS HOST DISEASE IN HSCT
GRAFT VS HOST DISEASE IN HSCTGRAFT VS HOST DISEASE IN HSCT
GRAFT VS HOST DISEASE IN HSCT
akshaya tomar
 
Liquid biopsy
Liquid biopsyLiquid biopsy
Liquid biopsy
Dr kusuma
 
Hematopoietic Cell Transplanation for Thalassemia Major
Hematopoietic Cell Transplanation for Thalassemia MajorHematopoietic Cell Transplanation for Thalassemia Major
Hematopoietic Cell Transplanation for Thalassemia Major
Northern California Comprehensive Thalassemia Center
 

What's hot (20)

Car tcell therapy
Car tcell therapyCar tcell therapy
Car tcell therapy
 
Hsct copy
Hsct   copyHsct   copy
Hsct copy
 
Neuroendocrine tumors of the lung (seminar)
Neuroendocrine tumors of the lung (seminar)Neuroendocrine tumors of the lung (seminar)
Neuroendocrine tumors of the lung (seminar)
 
HLA in Health & Disease
HLA in Health & DiseaseHLA in Health & Disease
HLA in Health & Disease
 
Know your COVID-19 Vaccine (Philippines)
Know your COVID-19 Vaccine (Philippines)Know your COVID-19 Vaccine (Philippines)
Know your COVID-19 Vaccine (Philippines)
 
20160219 Livia Marcato - Cell Free DNA and Liquid Biopsy
20160219 Livia Marcato - Cell Free DNA and Liquid Biopsy 20160219 Livia Marcato - Cell Free DNA and Liquid Biopsy
20160219 Livia Marcato - Cell Free DNA and Liquid Biopsy
 
Tumour immunology
Tumour immunologyTumour immunology
Tumour immunology
 
Precision Medicine in Oncology Informatics
Precision Medicine in Oncology InformaticsPrecision Medicine in Oncology Informatics
Precision Medicine in Oncology Informatics
 
Flowcytometry
FlowcytometryFlowcytometry
Flowcytometry
 
autologous bone marrow transplant
autologous bone marrow transplantautologous bone marrow transplant
autologous bone marrow transplant
 
Cancer Immuno editing
Cancer Immuno editingCancer Immuno editing
Cancer Immuno editing
 
Nick chen ppt presentation metronomic chemotherapy 2015
Nick chen   ppt presentation metronomic chemotherapy 2015Nick chen   ppt presentation metronomic chemotherapy 2015
Nick chen ppt presentation metronomic chemotherapy 2015
 
Cytokines
CytokinesCytokines
Cytokines
 
Gleason grading system
Gleason grading systemGleason grading system
Gleason grading system
 
Lect 6 a measles, mumps and rubella
Lect 6 a measles, mumps and rubellaLect 6 a measles, mumps and rubella
Lect 6 a measles, mumps and rubella
 
Stem Cell Transplantation in Hodgkin’s Lymphoma Past, Present and Future
Stem Cell Transplantation in  Hodgkin’s Lymphoma  Past, Present and FutureStem Cell Transplantation in  Hodgkin’s Lymphoma  Past, Present and Future
Stem Cell Transplantation in Hodgkin’s Lymphoma Past, Present and Future
 
Cancer vaccines
Cancer vaccinesCancer vaccines
Cancer vaccines
 
GRAFT VS HOST DISEASE IN HSCT
GRAFT VS HOST DISEASE IN HSCTGRAFT VS HOST DISEASE IN HSCT
GRAFT VS HOST DISEASE IN HSCT
 
Liquid biopsy
Liquid biopsyLiquid biopsy
Liquid biopsy
 
Hematopoietic Cell Transplanation for Thalassemia Major
Hematopoietic Cell Transplanation for Thalassemia MajorHematopoietic Cell Transplanation for Thalassemia Major
Hematopoietic Cell Transplanation for Thalassemia Major
 

Similar to The berlin patient

Hiv(human immunodeficiency virus)
Hiv(human immunodeficiency virus)Hiv(human immunodeficiency virus)
Hiv(human immunodeficiency virus)Ademola Dada
 
Hiv infection
Hiv  infectionHiv  infection
Hiv infection
MuhammadAbbaskhan9
 
Ghap hiv aids_handbook
Ghap hiv aids_handbookGhap hiv aids_handbook
Ghap hiv aids_handbook
Draus Klinberg Fur
 
HIV / AIDS Pathology
HIV / AIDS PathologyHIV / AIDS Pathology
HIV / AIDS Pathology
Imhotep Virtual Medical School
 
Aids Presentation
Aids Presentation Aids Presentation
Aids Presentation
Seena Binni
 
Oral manifestation of HIV
Oral manifestation of HIVOral manifestation of HIV
Oral manifestation of HIV
Bhargavi Sood
 
1Final Course Project OutlineFinal Course Project Outlin
1Final Course Project OutlineFinal Course Project Outlin1Final Course Project OutlineFinal Course Project Outlin
1Final Course Project OutlineFinal Course Project Outlin
AnastaciaShadelb
 
Hiv dr.tanushka
Hiv dr.tanushkaHiv dr.tanushka
Hiv dr.tanushka
Tanushka kandwal
 
HIV/AIDS
HIV/AIDSHIV/AIDS
HIV/AIDS
nwnashaee
 
2,000 proteins present in hiv virus
2,000 proteins present in hiv virus2,000 proteins present in hiv virus
2,000 proteins present in hiv virus
rita martin
 
HIV UPDATE TREATMENT
HIV UPDATE TREATMENTHIV UPDATE TREATMENT
HIV UPDATE TREATMENT
rafa64
 
Pathophysiology- Global Overview of Select Infectious Diseases
Pathophysiology- Global Overview  of Select Infectious DiseasesPathophysiology- Global Overview  of Select Infectious Diseases
Pathophysiology- Global Overview of Select Infectious Diseases
Imhotep Virtual Medical School
 
hivfinal-180417201129.pdf
hivfinal-180417201129.pdfhivfinal-180417201129.pdf
hivfinal-180417201129.pdf
MargamKamdak
 
HIV/AIDS Management
HIV/AIDS ManagementHIV/AIDS Management
HIV/AIDS Management
Sameh Abdel-ghany
 
hiv final management -180417201129.pdf
hiv final  management  -180417201129.pdfhiv final  management  -180417201129.pdf
hiv final management -180417201129.pdf
deborayilma
 
hiv / aids final managment -180417201129.pdf
hiv / aids final managment -180417201129.pdfhiv / aids final managment -180417201129.pdf
hiv / aids final managment -180417201129.pdf
deborayilma
 
HIV AND PERIODONTAL DISEASE
HIV AND PERIODONTAL DISEASEHIV AND PERIODONTAL DISEASE
HIV AND PERIODONTAL DISEASE
Dr.SANDIP Bhattacharyya
 
2014 Report: Medicines in Development for HIV/AIDS
2014 Report: Medicines in Development for HIV/AIDS2014 Report: Medicines in Development for HIV/AIDS
2014 Report: Medicines in Development for HIV/AIDS
PhRMA
 

Similar to The berlin patient (20)

Hiv(human immunodeficiency virus)
Hiv(human immunodeficiency virus)Hiv(human immunodeficiency virus)
Hiv(human immunodeficiency virus)
 
Hiv infection
Hiv  infectionHiv  infection
Hiv infection
 
Ghap hiv aids_handbook
Ghap hiv aids_handbookGhap hiv aids_handbook
Ghap hiv aids_handbook
 
HIV / AIDS Pathology
HIV / AIDS PathologyHIV / AIDS Pathology
HIV / AIDS Pathology
 
Aids Presentation
Aids Presentation Aids Presentation
Aids Presentation
 
Oral manifestation of HIV
Oral manifestation of HIVOral manifestation of HIV
Oral manifestation of HIV
 
Hivaids, racing to the finish point
Hivaids, racing to the finish pointHivaids, racing to the finish point
Hivaids, racing to the finish point
 
1Final Course Project OutlineFinal Course Project Outlin
1Final Course Project OutlineFinal Course Project Outlin1Final Course Project OutlineFinal Course Project Outlin
1Final Course Project OutlineFinal Course Project Outlin
 
Hiv dr.tanushka
Hiv dr.tanushkaHiv dr.tanushka
Hiv dr.tanushka
 
HIV/AIDS
HIV/AIDSHIV/AIDS
HIV/AIDS
 
2,000 proteins present in hiv virus
2,000 proteins present in hiv virus2,000 proteins present in hiv virus
2,000 proteins present in hiv virus
 
HIV UPDATE TREATMENT
HIV UPDATE TREATMENTHIV UPDATE TREATMENT
HIV UPDATE TREATMENT
 
Pathophysiology- Global Overview of Select Infectious Diseases
Pathophysiology- Global Overview  of Select Infectious DiseasesPathophysiology- Global Overview  of Select Infectious Diseases
Pathophysiology- Global Overview of Select Infectious Diseases
 
hivfinal-180417201129.pdf
hivfinal-180417201129.pdfhivfinal-180417201129.pdf
hivfinal-180417201129.pdf
 
HIV/AIDS Management
HIV/AIDS ManagementHIV/AIDS Management
HIV/AIDS Management
 
hiv final management -180417201129.pdf
hiv final  management  -180417201129.pdfhiv final  management  -180417201129.pdf
hiv final management -180417201129.pdf
 
hiv / aids final managment -180417201129.pdf
hiv / aids final managment -180417201129.pdfhiv / aids final managment -180417201129.pdf
hiv / aids final managment -180417201129.pdf
 
HIV AND PERIODONTAL DISEASE
HIV AND PERIODONTAL DISEASEHIV AND PERIODONTAL DISEASE
HIV AND PERIODONTAL DISEASE
 
Jordan Schneider Benchmark 2
Jordan Schneider Benchmark 2Jordan Schneider Benchmark 2
Jordan Schneider Benchmark 2
 
2014 Report: Medicines in Development for HIV/AIDS
2014 Report: Medicines in Development for HIV/AIDS2014 Report: Medicines in Development for HIV/AIDS
2014 Report: Medicines in Development for HIV/AIDS
 

Recently uploaded

2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
Sandy Millin
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
Jisc
 
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
Nguyen Thanh Tu Collection
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
siemaillard
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
Jisc
 
The Art Pastor's Guide to Sabbath | Steve Thomason
The Art Pastor's Guide to Sabbath | Steve ThomasonThe Art Pastor's Guide to Sabbath | Steve Thomason
The Art Pastor's Guide to Sabbath | Steve Thomason
Steve Thomason
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
 
The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
GeoBlogs
 
Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
RaedMohamed3
 
How to Break the cycle of negative Thoughts
How to Break the cycle of negative ThoughtsHow to Break the cycle of negative Thoughts
How to Break the cycle of negative Thoughts
Col Mukteshwar Prasad
 
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
BhavyaRajput3
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
Jisc
 
How to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERPHow to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERP
Celine George
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
Atul Kumar Singh
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
JosvitaDsouza2
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptxMARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
bennyroshan06
 
Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)
rosedainty
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
joachimlavalley1
 
ESC Beyond Borders _From EU to You_ InfoPack general.pdf
ESC Beyond Borders _From EU to You_ InfoPack general.pdfESC Beyond Borders _From EU to You_ InfoPack general.pdf
ESC Beyond Borders _From EU to You_ InfoPack general.pdf
Fundacja Rozwoju Społeczeństwa Przedsiębiorczego
 

Recently uploaded (20)

2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...2024.06.01 Introducing a competency framework for languag learning materials ...
2024.06.01 Introducing a competency framework for languag learning materials ...
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
 
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
GIÁO ÁN DẠY THÊM (KẾ HOẠCH BÀI BUỔI 2) - TIẾNG ANH 8 GLOBAL SUCCESS (2 CỘT) N...
 
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
aaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaaa
 
How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...How libraries can support authors with open access requirements for UKRI fund...
How libraries can support authors with open access requirements for UKRI fund...
 
The Art Pastor's Guide to Sabbath | Steve Thomason
The Art Pastor's Guide to Sabbath | Steve ThomasonThe Art Pastor's Guide to Sabbath | Steve Thomason
The Art Pastor's Guide to Sabbath | Steve Thomason
 
Chapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptxChapter 3 - Islamic Banking Products and Services.pptx
Chapter 3 - Islamic Banking Products and Services.pptx
 
The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
 
Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
 
How to Break the cycle of negative Thoughts
How to Break the cycle of negative ThoughtsHow to Break the cycle of negative Thoughts
How to Break the cycle of negative Thoughts
 
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
 
How to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERPHow to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERP
 
Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
 
1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx1.4 modern child centered education - mahatma gandhi-2.pptx
1.4 modern child centered education - mahatma gandhi-2.pptx
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptxMARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
 
Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)
 
Additional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdfAdditional Benefits for Employee Website.pdf
Additional Benefits for Employee Website.pdf
 
ESC Beyond Borders _From EU to You_ InfoPack general.pdf
ESC Beyond Borders _From EU to You_ InfoPack general.pdfESC Beyond Borders _From EU to You_ InfoPack general.pdf
ESC Beyond Borders _From EU to You_ InfoPack general.pdf
 

The berlin patient

  • 2. Today we are going to discuss about another remarkable victory of medical science . OUR BIG IDEA 2
  • 3. HIV is a virus that targets and alters the immune system, increasing the risk and impact of other infections and diseases. Without treatment, the infection might progress to an advanced disease stage called AIDS. EXPLAINING HIVANDAIDS BRIEFLY What is HIV? Human immunodeficiency virus (HIV) is a virus that attacks immune cells called CD4 cells, which are a type of T cell. These are white blood cells that move around the body, detecting faults and anomalies in cells as well as infections. When HIV targets and infiltrates these cells, it reduces the body's ability to combat other diseases. This increases the risk and impact of opportunistic infections and cancers. However, a person can carry HIV without experiencing symptoms for a long time. HIV is a lifelong infection. However, receiving treatment and managing the disease effectively can prevent HIV from reaching a severe level and reduce the risk of a person passing on the virus. What is AIDS? AIDS is the most advanced stage of HIV infection. Once HIV infection develops into AIDS, infections and cancer pose a greater risk. Without treatment, HIV infection is likely to develop into AIDS as the immune system gradually wears down. 3
  • 4. Causes HIV is a sexually transmitted infection (STI). It can also be spread by contact with infected blood or from mother to child during pregnancy, childbirth or breast-feeding. Symptoms Some people with HIV do not show symptoms until months or even years after contracting the virus. However, around 80 percent of people may develop a set of flu-like symptoms known as acute retroviral syndrome. The early symptoms of HIV infection may include: Fever, chills, joint pain, muscle aches, sore throat, Sweats(particularly at night), enlarged glands, a red rash, tiredness. Without medication, HIV weakens the ability to fight infection. The person becomes vulnerable to serious illnesses. Symptoms of late-stage HIV infection may include: i)blurred vision, ii)diarrhoea, which is usually persistent or chronic, iii)dry cough, a fever of over 100 °F (37 °C) lasting for weeks, iv)night sweats, v)permanent tiredness, shortness of breath, or dyspnoea, swollen glands lasting for weeks, vi)unintentional weight loss, white spots on the tongue or mouth. 4
  • 5. HIV LIFECYCLE Stages of HIV lifecycle: 5 1. Binding and fusion The virus attaches itself to a T-helper cell and releases HIV into the cell. 2. Conversion and integration Once inside the T-helper cell, HIV changes its genetic material so it can enter the nucleus of the cell and take control of it. 3. Replication The infected T-helper cell then produces more HIV proteins that are used to produce more HIV particles inside the cell. 4. Assembly, budding and maturation The new HIV particles are then released from the T-helper cell into the bloodstream which infect other cells; and so the process begins again.
  • 6. WHO IS “ THE BERLIN PATIENT ” ? Timothy Ray Brown (born 1966) is an American considered to be the first person cured of HIV/AIDS. Brown was called "The Berlin Patient" at the 2008 Conference on Retroviruses and Opportunistic Infections, where his cure was first announced, in order to preserve his anonymity, and because he lived in, and was treated in Berlin. He chose to come forward in late 2010. “I didn’t want to be the only person cured,” he said. “I wanted to do what I could to make [a cure] possible. My first step was releasing my name and image to the public.” 6
  • 7. PROCEDURE(HOWDIDBROWNRIDHIMSELFOFHIV): 7 Brown was diagnosed with HIV in 1995 while studying in Berlin, Germany. After controlling the virus for many years with antiretroviral therapy, Brown was diagnosed with Acute Myeloid Leukaemia (AML) and in 2007 underwent stem cell transplantation after unsuccessful chemotherapy . His physician, Dr. Gero Hütter, at Charité Hospital in Berlin, arranged for him to receive a hematopoietic stem cell transplant from a donor with the "delta32" mutation on the CCR5 receptor. Despite enduring complications and undergoing a second transplant from the same donor in 2008, the outcome was ultimately a success. Nearly eight years after his transplant, Brown remains free of both his cancer and readily detectable HIV.
  • 8. VARIOUS STEPS THAT HAD PLAYED SIGNIFICANT ROLE IN THE TREATMENT Figure1: Genotyping of CCR5 Alleles 8 (Contd.)
  • 9. VARIOUS STEPS THAT HAD PLAYED SIGNIFICANT ROLE IN THE TREATMENT(CONTD.) Figure 2: Cellular and Humoral Immune Response to HIV-1 9 (Contd.)
  • 10. VARIOUS STEPS THAT HAD PLAYED SIGNIFICANT ROLE IN THE TREATMENT(CONTD.) Figure 3: Clinical Course and HIV-1 Viremia 10 Figure 4: Expression of CD Surface Antigen and Chemokine Core receptor in the patient’s rectal mucosa
  • 11. TEN YEARSAFTER THE ‘BERLIN PATIENT,’ DOCTORS ANNOUNCEASECOND PERSON HAS BEEN EFFECTIVELY ‘CURED’ OF HIV 11 For the second time, doctors appear to have put HIV into “sustained remission” with a stem cell transplant-effectively curing the recipient. The researchers reported in the journal Nature what they hope will be a triumph: a man in London H.I.V. and may have been cured of the infection. The London Patient, as he is being called, first and then later developed Hodgkin’s lymphoma. The cancer was resistant to standard chemotherapy, so advised more intensive chemotherapy, along with a bone-marrow transplant. He received bone-marrow stem cells from a healthy donor who had the CCR5 mutation. When the Patient’s immune system regrew after the transplant, it lacked the protein and was impervious to the contracted. Unable to take root in his cells, the virus appears to have passed. Unlike Brown, though, this cancer treatment didn’t involve full-body radiation, and his chemotherapy was also far gentler.
  • 12. HIV research has come a long way since the disease was discovered in the 1980’s. Antiretroviral therapy was a major milestone that has changed the lives of millions. APOSSIBILITY OF HIV FREE WORLD ‘The Berlin Patient’, Timothy Ray Brown, became first person to be effectively cured of HIV in 2007. If indeed, Timothy Brown has been functionally cured of his HIV infection, he then has provided us with a blueprint from which to work. In fact, much of our ongoing research endeavours were inspired by the biological mechanisms likely exploited to bring about this breakthrough. By reverse engineering his pathway to cure, we hope to recapitulate his success and develop a feasible therapy approach that would be available to the vast majority of HIV-infected individuals. Nearly 12 years after “The Berlin patient” doctors announced a second person has been effectively ‘cured’ of HIV. The treatment procedure was almost similar to that of Brown. These two cases provide a proof of principle about the potential of stem cells that lack CCR5. Those techniques may be used to genetically alter the cells of people with H.I.V., inactivating the CCR5 gene. Those people should then become resistant to the virus, and hopefully recapitulate the outcomes of the Berlin and London patients. 12
  • 14. ACKNOWLEDGEMENT 14 Our team would like to express our deepest appreciation to all those who provided us the possibility to complete this report. A special gratitude we give to our respected teacher, Ms. Meenakshi Dey, whose contribution in stimulating suggestions and encouragement, helped us to coordinate our project especially in writing this report. We have to appreciate the guidance given by other supervisor as well as the panels especially in our project presentation that has improved our presentation skills thanks to their comment and advices.
  • 15. THANK YOU Akanksha Kumari 17/CSE/118 Adriza Bera Aditya Kumar Aishik Das Aditya Prakash Adarsha Dinda 17/CSE/120 17/CSE/119 17/CSE/121 17/CSE/122 17/CSE/123